normative
Marginal improvements get patent-protected and over-prescribed
Small incremental improvements—such as a drug absorbed more easily or taken less often—are awarded patent monopolies and priced many-fold above generics, then preferentially prescribed even though the system fails to encourage patients toward equally effective generics, which is a serious flaw of the current arrangement.
normativepending
Speaker
Russ RobertsEvidence Quote
“it seems to me that should not be privileged with the monopoly of a patent”
Created: 6/13/2026, 12:18:13 AM
Your notes
Loading notes...